Neoadjuvant chemotherapy and bladder-sparing surgery for invasive bladder cancer: ten-year outcome

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
H W HerrH I Scher

Abstract

To evaluate the 10-year outcome of patients with invasive (T2-3N0M0, staged according to the tumor, node, metastasis system) bladder cancer who responded completely to a combination of methotrexate, vinblastine, adriamycin, and cisplatin (MVAC) chemotherapy followed by bladder-sparing surgery. Of 111 surgical candidates who received neoadjuvant MVAC, 60 (54%) achieved a complete clinical response (T0) on transurethral resection (TUR) of the primary tumor site. Of these, 28 requested follow-up with TUR alone, 15 had a partial cystectomy, and 17 elected a radical cystectomy. The patients were followed up for a median of 10 years (range, 8 to 13 years). Of 43 patients who had bladder-sparing surgery, 32 (74%) are alive, which includes 25 (58%) with an intact functioning bladder. Twenty-four patients (56%) developed bladder tumor recurrences from 5 to 96 months, which were invasive in 13 (30%) and superficial in 11 (26%). Thirteen patients required a salvage cystectomy, of whom 6 died, which includes 4 (9%) from a new invasive neoplasm. Of the 17 patients who had radical cystectomy, 11 (65%) are alive. The majority of patients with invasive bladder tumors who achieve T0 status after neoadjuvant MVAC chemotherapy preserve their blad...Continue Reading

Citations

Nov 23, 2006·World Journal of Urology·Peter C BlackColin P Dinney
Jun 21, 2002·European Urology·Willem OosterlinckUNKNOWN European Association of Urology (EAU) Working Group on Oncological Urology
Feb 14, 2002·Critical Reviews in Oncology/hematology·Filippo de BraudCora N Sternberg
Jun 26, 2001·Clinical and Laboratory Haematology·K Shimizu, K Imaida
Mar 29, 2000·BJU International·C N Sternberg, F Calabrò
Jan 26, 2012·Current Opinion in Oncology·Kirk A KeeganPeter E Clark
Sep 10, 2011·Therapeutic Advances in Urology·Arjun BalarMatthew I Milowsky
Jul 28, 2011·OncoTargets and Therapy·Prakash VishnuWinston W Tan
Jun 22, 2005·European Urology·Dimitrios PectasidesMaria Nikolaou
Oct 2, 2012·Critical Reviews in Oncology/hematology·Damien PouesselStéphane Culine
Nov 28, 2008·BJU International·Raymond H MakWilliam U Shipley
May 1, 2017·The Journal of Urology·Sam S ChangJeffrey M Holzbeierlein
Mar 31, 2004·The Medical Clinics of North America·Michael J Droller
Jul 20, 1999·The Journal of Urology·J E Montie
Jan 23, 2009·European Urology·Arnulf StenzlJ Alfred Witjes
Jul 2, 2005·Critical Reviews in Oncology/hematology·Guru Sonpavde, Daniel P Petrylak
Oct 7, 2003·American Journal of Clinical Oncology·Yukio KageyamaKazunori Kihara
May 10, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gopa IyerDean F Bajorin
Aug 10, 2004·Current Opinion in Urology·J Erik Busby, Christopher P Evans
Apr 4, 2003·Cancer·E David CrawfordUNKNOWN Southwest Oncology Group
Dec 31, 2009·Journal of Endourology·Satya AllaparthiK C Balaji
Jun 8, 2001·Journal of Endourology·B M Grob, R J Macchia
May 16, 2006·The Journal of Urology·Hugh A G Fisher
Nov 4, 2006·World Journal of Urology·Jason A EfstathiouWilliam U Shipley
May 12, 2007·Wiener medizinische Wochenschrift·Daniel MeyerDaniel S Engeler
Dec 21, 2000·Current Oncology Reports·R B Natale
Jun 12, 2002·Current Treatment Options in Oncology·J I Izawa, H B Grossman
Jun 26, 2008·Nature Clinical Practice. Oncology·Toni K Choueiri, Derek Raghavan
Jun 19, 2008·Nature Clinical Practice. Urology·Vito Pansadoro, Paolo Emiliozzi
Dec 19, 2008·International Journal of Clinical Oncology·Faysal A YafiWassim Kassouf
May 31, 2002·Expert Opinion on Pharmacotherapy·Sergiusz NawrockiIwona Skoneczna

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.